Sustainability | June 04, 2022
Organon introduces global ESG strategy
Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health
Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health
To address the preventive & primary healthcare delivery gaps in India
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
Innate to receive $5M milestone payment from AstraZeneca
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Subscribe To Our Newsletter & Stay Updated
